Consensus on diagnosis and management of Cushing's disease: a guideline update

M Fleseriu, R Auchus, I Bancos… - The lancet Diabetes & …, 2021 - thelancet.com
Cushing's disease requires accurate diagnosis, careful treatment selection, and long-term
management to optimise patient outcomes. The Pituitary Society convened a consensus …

Management of patients with persistent or recurrent Cushing's disease after initial pituitary surgery

C Capatina, JM Hinojosa-Amaya… - Expert Review of …, 2020 - Taylor & Francis
Introduction Treatment options for persistent and recurrent Cushing's disease (CD) include
an individualized approach for repeat surgery, medical treatment, radiation therapy (RT) …

Recurrent Cushing disease: an extensive review on pros and cons of different therapeutic approaches

M Sabahi, P Ghasemi-Nesari, SF Maroufi… - World Neurosurgery, 2023 - Elsevier
Objective Recurrent Cushing disease (CD) is characterized by the reappearance of clinical
and hormonal aspects of hypercortisolism that occur more than 6 months after an initial post …

Surgical and radiosurgical treatment strategies for Cushing's disease

A Bunevicius, ER Laws, ML Vance, S Iuliano… - Journal of Neuro …, 2019 - Springer
Introduction Cushing's disease (CD) is rare disorder that should be adequately managed to
optimize long-term prognosis. Treatment of CD is multidisciplinary and often includes …

Updates in the outcomes of radiation therapy for Cushing's disease

ML Gheorghiu - Best Practice & Research Clinical Endocrinology & …, 2021 - Elsevier
External radiation therapy (RT) directed to the pituitary gland is generally recommended in
patients with Cushing's disease (CD) as adjuvant to transsphenoidal surgery, among other …

Treatment of recurrent and persistent Cushing's disease after first transsphenoidal surgery: lessons learned from an international meta-analysis

C Perez-Vega, A Ramos-Fresnedo, S Tripathi… - Pituitary, 2022 - Springer
Purpose Transsphenoidal surgery (TSS) is the first-line treatment for patients with Cushing's
Disease (CD). Recurrence rates after a first TSS range between 3 and 22% within 3 years …

Early versus late Gamma Knife radiosurgery for Cushing's disease after prior resection: results of an international, multicenter study

A Bunevicius, H Kano, CC Lee, M Krsek… - Journal of …, 2020 - thejns.org
OBJECTIVE The optimal time to perform stereotactic radiosurgery after incomplete resection
of adrenocorticotropic hormone (ACTH)–producing pituitary adenoma in patients with …

Gamma Knife surgery for recurrent or persistent Cushing disease: long-term results and evaluation of biological effective dose in a series of 26 patients.

A Balossier, C Tuleasca, C Cortet-Rudelli, G Soto-Ares… - 2021 - lilloa.univ-lille.fr
INTRODUCTION: Here we report long-term results after stereotactic radiosurgery (SRS) with
Gamma Knife (GKRS) for Cushing disease. We further evaluated the potential role of the …

[HTML][HTML] Thyroid-stimulating hormone-secreting pituitary adenomas: single institutional experience of 14 consecutive cases

J Byun, JH Kim, YH Kim, YH Cho… - Journal of Korean …, 2020 - synapse.koreamed.org
Objective Thyroid-stimulating hormone (TSH)-secreting pituitary adenoma (PA) is an
extremely rare functioning form of PA that accounts for 0.7–2% of all such cases. The …

Pituitary adenomas

JC Ganz - Progress in Brain Research, 2022 - Elsevier
Pituitary adenomas produce a complex collection of disorders. Some are incidental findings.
Some distort local anatomical structures which can lead to disorders of vision or hormone …